Spironolactone in the Treatment of Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Design and Baseline Characteristics of the SPIRIT-HF-DZHK08 Trial.
- DOI
- 10.1093/ejhf/xuag222
- Published
- 2026 Jul 28
- Container
- European journal of heart failure
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/ejhf/xuag222,
title = {Spironolactone in the Treatment of Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Design and Baseline Characteristics of the SPIRIT-HF-DZHK08 Trial.},
author = {Zurkan D and Pieske B and Petutschnigg J and Verheyen N and Khan MS and Ferreira JP and Girerd N and Biegus J and Felix S and Hasenfuß G and Mosterd A and Pitt B and Ponikowski P and Shah S and Trippel T and Zannad F and Placzek M and Friede T and Anker SD and Edelmann F},
year = {2026},
journal = {European journal of heart failure},
doi = {10.1093/ejhf/xuag222},
url = {https://doi.org/10.1093/ejhf/xuag222}
}RIS
TY - JOUR TI - Spironolactone in the Treatment of Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Design and Baseline Characteristics of the SPIRIT-HF-DZHK08 Trial. AU - Zurkan D AU - Pieske B AU - Petutschnigg J AU - Verheyen N AU - Khan MS AU - Ferreira JP AU - Girerd N AU - Biegus J AU - Felix S AU - Hasenfuß G AU - Mosterd A AU - Pitt B AU - Ponikowski P AU - Shah S AU - Trippel T AU - Zannad F AU - Placzek M AU - Friede T AU - Anker SD AU - Edelmann F PY - 2026 JO - European journal of heart failure DO - 10.1093/ejhf/xuag222 UR - https://doi.org/10.1093/ejhf/xuag222 ER -
APA
D, Z., B, P., J, P., N, V., MS, K., JP, F., N, G., J, B., S, F., G, H., A, M., B, P., P, P., S, S., T, T., F, Z., M, P., T, F., SD, A., & F, E. (2026). Spironolactone in the Treatment of Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Design and Baseline Characteristics of the SPIRIT-HF-DZHK08 Trial.. European journal of heart failure. https://doi.org/10.1093/ejhf/xuag222
Source records
- pubmed · retrieved 2026-09-25T23:10:10.039Z